Malaysian, Philippines, Vietnam Eyed By Valeant For More M&A
This article was originally published in PharmAsia News
Executive Summary
Malaysia, The Philippines and Vietnam are being eyed by Valeant Pharmaceuticals International for future mergers and acquisitions as the Canadian drug maker focuses on M&As instead of research and development.